596 related articles for article (PubMed ID: 15082879)
1. Effects of indomethacin and rofecoxib on gastric mucosal damage in normal and Helicobacter pylori-infected mongolian gerbils.
Kanatani K; Ebata M; Murakami M; Okabe S
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):207-22. PubMed ID: 15082879
[TBL] [Abstract][Full Text] [Related]
2. Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
Brzozowski T; Konturek PC; Kwiecien S; Konturek SJ; Pajdo R; Drozdowicz D; Ptak A; Pawlik M; Stachura J; Pawlik WW; Hahn EG
J Physiol Pharmacol; 2003 Mar; 54(1):33-51. PubMed ID: 12674217
[TBL] [Abstract][Full Text] [Related]
3. Eradication of Helicobacter pylori significantly reduced gastric damage in nonsteroidal anti-inflammatory drug-treated Mongolian gerbils.
Chang CC; Chen SH; Lien GS; Lou HY; Hsieh CR; Fang CL; Pan S
World J Gastroenterol; 2005 Jan; 11(1):104-8. PubMed ID: 15609406
[TBL] [Abstract][Full Text] [Related]
4. Functional and morphological aspects of Helicobacter pylori-induced gastric cancer in Mongolian gerbils.
Konturek PC; Brzozowski T; Konturek SJ; Kwiecień S; Pajdo R; Drozdowicz D; Stachura J; Karczewska E; Hahn EG
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):745-54. PubMed ID: 12811305
[TBL] [Abstract][Full Text] [Related]
5. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
Brzozowski T; Konturek PC; Mierzwa M; Drozdowicz D; Bielanski W; Kwiecien S; Konturek SJ; Stachura J; Pawlik WW; Hahn EG
Helicobacter; 2006 Feb; 11(1):10-20. PubMed ID: 16423085
[TBL] [Abstract][Full Text] [Related]
6. Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils.
Nomura S; Suzuki H; Masaoka T; Kurabayashi K; Ishii H; Kitajima M; Nomoto K; Hibi T
Helicobacter; 2005 Feb; 10(1):43-52. PubMed ID: 15691314
[TBL] [Abstract][Full Text] [Related]
7. Effects of antioxidant vitamin supplements on Helicobacter pylori-induced gastritis in Mongolian gerbils.
Sun YQ; Girgensone I; Leanderson P; Petersson F; Borch K
Helicobacter; 2005 Feb; 10(1):33-42. PubMed ID: 15691313
[TBL] [Abstract][Full Text] [Related]
8. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
9. Effects of aspirin on the development of Helicobacter pylori-induced gastric inflammation and heterotopic proliferative glands in Mongolian gerbils.
Li GQ; Xia HH; Chen MH; Tsukamoto T; Tatematsu M; Gu Q; Qiao L; Cho CH; So WH; Yuen MF; Hu PJ; Liang YJ; Lin HL; Chan AO; Wong BC
Helicobacter; 2008 Feb; 13(1):20-9. PubMed ID: 18205662
[TBL] [Abstract][Full Text] [Related]
10. Development of gastric adenocarcinoma in Mongolian gerbils after long-term infection with Helicobacter pylori.
Zheng Q; Chen XY; Shi Y; Xiao SD
J Gastroenterol Hepatol; 2004 Oct; 19(10):1192-8. PubMed ID: 15377299
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of a clinical isolate of urease-negative Helicobacter pylori and its ability to induce gastric ulcers in Mongolian gerbils.
Mine T; Muraoka H; Saika T; Kobayashi I
Helicobacter; 2005 Apr; 10(2):125-31. PubMed ID: 15810942
[TBL] [Abstract][Full Text] [Related]
12. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].
Keto Y; Ebata M; Okabe S
Nihon Yakurigaku Zasshi; 2001 Oct; 118(4):259-68. PubMed ID: 11680169
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effect of rice extract on Helicobacter pylori infection in a Mongolian gerbil model.
Murakami M; Ota H; Sugiyama A; Ishizone S; Maruta F; Akita N; Okimura Y; Kumagai T; Jo M; Tokuyama T
J Gastroenterol; 2005 May; 40(5):459-66. PubMed ID: 15942710
[TBL] [Abstract][Full Text] [Related]
15. FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils.
Takahashi S; Keto Y; Fujita T; Uchiyama T; Yamamoto A
J Pharmacol Exp Ther; 2001 Jan; 296(1):48-56. PubMed ID: 11123361
[TBL] [Abstract][Full Text] [Related]
16. Long-standing gastric mucosal barrier dysfunction in Helicobacter pylori-induced gastritis in mongolian gerbils.
Sun YQ; Söderholm JD; Petersson F; Borch K
Helicobacter; 2004 Jun; 9(3):217-27. PubMed ID: 15165257
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with sterigmatocystin, a fungus toxin, enhances the development of intestinal metaplasia of gastric mucosa in Helicobacter pylori-infected Mongolian gerbils.
Ma F; Misumi J; Zhao W; Aoki K; Kudo M
Scand J Gastroenterol; 2003 Apr; 38(4):360-9. PubMed ID: 12739707
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils.
Bhang CS; Lee HS; Kim SS; Song HJ; Sung YJ; Kim JI; Chung IS; Sun HS; Park DH; Lee YS
Helicobacter; 2002 Feb; 7(1):14-21. PubMed ID: 11886470
[
